Synapse - Andrew Seidman

Results (158)

Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage human epidermal growth factor receptor 2–negative breast cancer

Journal Article

Cadoo, K. A.; Kaufman, P. A.; Seidman, A. D.; Chang, C.; Xing, D.; Traina, T. A.
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Phase II study of paclitaxel and dasatinib in metastatic breast cancer

Journal Article

Morris, P. G.; Rota, S.; Cadoo, K.; Zamora, S.; Patil, S.; D'Andrea, G.; Gilewski, T.; Bromberg, J.; Dang, C.; Dickler, M.; more...
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

Characteristics and prognostic factors for patients with HER2-overexpressing breast cancer and brain metastases in the era of HER2-targeted therapy: An argument for earlier detection

Journal Article

Morikawa, A.; Wang, R.; Patil, S.; Diab, A.; Yang, J.; Hudis, C. A.; McArthur, H. L.; Beal, K.; Seidman, A. D.
Clinical Breast Cancer (2018)

Fulltext@MSK | Save

A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients

Journal Article

Bao, T.; Seidman, A. D.; Piulson, L.; Vertosick, E.; Chen, X.; Vickers, A. J.; Blinder, V. S.; Zhi, W. I.; Li, Q.; Vahdat, L. T.; more...
European Journal of Cancer (2018)

Fulltext@MSK | Save

Living with chronic pain: Perceptions of breast cancer survivors

Journal Article

Bao, T.; Seidman, A.; Li, Q.; Seluzicki, C.; Blinder, V.; Meghani, S. H.; Farrar, J. T.; Mao, J. J.
Breast Cancer Research and Treatment (2018)

Fulltext@MSK | Save

Oncologic outcome of pregnancy associated breast cancer: A case-control study

Meeting Abstract

McCartan, D.; Kamer, S.; Eaton, A.; Seidman, A.; Murphy, C.; Gemignani, M.; Goldfarb, S.
Cancer Research (2017)

Fulltext@MSK | Save

Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: Prevalence, risk factors, and fall risk

Journal Article

Bao, T.; Basal, C.; Seluzicki, C.; Li, S. Q.; Seidman, A. D.; Mao, J. J.
Breast Cancer Research and Treatment (2016)

Fulltext@MSK | Save

Phase 2 study of dose-dense doxorubicin and cyclophosphamide followed by eribulin mesylate with or without prophylactic growth factor for adjuvant treatment of early-stage breast cancer

Meeting Abstract

Cadoo, K.; Kaufman, P. A.; Hudis, C.; Chang, C.; Berrak, E.; Song, J.; Seidman, A. D.; Traina, T. A.
Cancer Research (2016)

Fulltext@MSK | Save

Integration of multi-modality treatment planning for early stage breast cancer (BC) into Watson for Oncology, a Decision Support System: Seeing the forest and the trees